| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-14 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-13 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.21 | 6e-12 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-11 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |